期刊论文详细信息
Health and Quality of Life Outcomes
A short questionnaire for the assessment of quality of life in patients with chronic obstructive pulmonary disease: psychometric properties of VQ11
Christian Préfaut2  Franck Soyez1  Gregory Ninot1 
[1] Laboratory Epsylon, EA4556 Dynamics of Human Abilities & Health Behaviors, University MONTPELLIER 1, Montpellier F-34000, France;U1046 INSERM Physiologie et Physiopathologie du Coeur et du Muscle, University MONTPELLIER 1, CHRU Montpellier, Montpellier F-34295, France
关键词: VQ11;    Validity;    Health-related quality of life;    Brief questionnaire;    Chronic obstructive pulmonary disease;   
Others  :  822242
DOI  :  10.1186/1477-7525-11-179
 received in 2013-06-21, accepted in 2013-09-25,  发布年份 2013
PDF
【 摘 要 】

Background

There is a need for a validated short instrument that can be used in routine practice to quantify potential short-term change in Health-Related Quality of Life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD). Our aim is to determine the validity and reliability of the VQ11 questionnaire dedicated to the routine assessment of HRQoL.

Methods

181 COPD patients (40–85 yrs, I to IV GOLD stages) completed the VQ11, and several tests. One week later, 49 of these patients completed the VQ11 again.

Results

Confirmatory factor analysis supported the two-level hierarchical structure of the VQ11 with 11 items covering three components and HRQoL at a higher level. The VQ11 showed good internal consistency and good reproducibility (r = 0.88). Concurrent validity showed significant correlations between VQ11 total scores and St George’s Respiratory Questionnaire-C (r = 0.70), Short Form-36 (r = -0.66 for the physical component and -0.63 for the mental component). We obtained significant correlations with MRC Dyspnea Grades (r = 0.59), the Hospital Anxiety and Depression Scale total score (r = 0.62), and the BODE index (r = 0.53).

Conclusion

The VQ11 has good measurement properties and provides a valid and reliable measure of COPD-specific HRQoL. It is ready for use in routine practice.

Clinical registration

The study was approved by the University of Montpellier 1 Ethics Committee and the Regional Ethics Committee (authorization number: A00332-53).

【 授权许可】

   
2013 Ninot et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140712095215135.pdf 276KB PDF download
Figure 1. 37KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, Anto JM: Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:680-685.
  • [2]Jones PW, Quirk FH, Baveystock CM: The St George’s respiratory questionnaire. Respir Med 1991, 85 Suppl B:25-31. discussion 33–27
  • [3]Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-778.
  • [4]Global Initiative for Chronic Obstructive Lung Disease: Global strategy for diagnosis, management, and prevention of COPD. In Book Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD Edited by Editor eds. 2009. http://www.goldcopd.org/ webcite
  • [5]Jones PW: Quality of life measurement for patients with diseases of the airways. Thorax 1991, 46:676-682.
  • [6]Jones PW, Kaplan RM: Methodological issues in evaluating measures of health as outcomes for COPD. Eur Respir J Suppl 2003, 41:13s-18s.
  • [7]Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
  • [8]Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation included: a randomized controlled trial. Lancet 2000, 355:362-368.
  • [9]Ries AL, Kaplan RM, Myers R, Prewitt LM: Maintenance after pulmonary rehabilitation in chronic lung disease. Am J Respir Crit Care Med 2003, 167:880-888.
  • [10]Brooks D, Krip B, Mangovski-Alzamora S, Goldstein RS: The effect of post-rehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J 2002, 20:20-29.
  • [11]van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF: Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13. BioMed Central Full Text
  • [12]Tsai C-L, Hodder RV, Page JH, Cydulka RK, Rowe BH, Camargo CA Jr: The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol 2008, 61:489-497.
  • [13]Perez T, Arnould B, Grosbois JM, Bosch V, Guillemin I, Bravo ML, Brun M, Tonnel AB, Group TS: Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:9-18.
  • [14]Jones PW, Harding G, Berry P, Wiklund I, Kline Leidy N: Development and first validation of the COPD assessment test. Eur Respir J 2009, 34:648-654.
  • [15]Ninot G, Soyez F, Fiocco S, Nassih K, Morin AJS, Prefaut C: [The VQ11, a short health-related quality of life questionnaire for routine practice in COPD patients]. Le VQ11, un questionnaire de qualite de vie specifique a la BPCO utilisable en clinique. Rev Mal Respir 2010, 27:472-481.
  • [16]Curtis JR, Martin DP, Martin TR: Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997, 156:1032-1039.
  • [17]Mahler DA: How should health-related quality of life be assessed in patients with COPD? Chest 2000, 117:54S-57S.
  • [18]Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Hughes BM, Weinman J, Kaplan RM, Rabe KF: 50 years of psychological research on patients with COPD–road to ruin or highway to heaven? Respir Med 2009, 103:3-11.
  • [19]Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, Anxiety AWP, Depression in C, Kunik M, et al.: Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008, 134:43S-56S.
  • [20]Marsh HW, Ellis LA, Parada RH, Richards G, Heubeck BG: A short version of the Self Description Questionnaire II: operationalizing criteria for short-form evaluation with new applications of confirmatory factor analyses. Psychol Assess 2005, 17:81-102.
  • [21]Streiner DL, Norman GR: Health Measurement Scales: a practical guide to their development and use. Oxford: Oxford University Press; 2008.
  • [22]Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
  • [23]Leplege A, Ecosse E, Verdier A, Perneger TV: The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998, 51:1013-1023.
  • [24]Meguro M, Barley EA, Spencer S, Jones PW: Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire. Chest 2007, 132:456-463.
  • [25]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
  • [26]Ninot G, Delignières D, Fortes M: L’évaluation de l’estime de soi dans le domaine corporel:35–48. Revue STAPS 2000, 53:35-48.
  • [27]Fox KR, Corbin CB: The physical self-perception profile: development and preliminary validation. J Sport Exerc Psychol 1989, 11:408-430.
  • [28]Mahler DA, Wells CK: Evaluation of clinical methods for rating dyspnea. Chest 1988, 93:580-586.
  • [29]Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:785-790.
  • [30]Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
  • [31]Troosters T, Gosselink R, Decramer M: Six minute walking distance in healthy elderly subjects. Eur Respir J 1999, 14:270-274.
  • [32]Byrne BM: Factor analytic models viewing the structure of an assessment instrument from three perspectives. J Pers Assess 2005, 85:17-32.
  • [33]Hu LT, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999, 6:1-55.
  • [34]Vandenberg RJ, Lance CE: A review and synthesis of the measurement invariance literature: suggestions, practices, and recommendations for organizational research. Organ Res Meth 2000, 3:4-70.
  • [35]MacCallum RC, Browne MW, Sugawara HM: Power analysis and determination of sample size for covariance structure modeling. Psychol Methods 1996, 1:130-149.
  • [36]Kaplan RM, Ries AL, Reilly J, Mohsenifar Z, Grp NETTR: Measurement of health-related quality of life in the national emphysema treatment trial. Chest 2004, 126:781-789.
  • [37]Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley EA: Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005, 127:1205-1211.
  • [38]Jones PW: Health status measurement in chronic obstructive pulmonary disease. Thorax 2001, 56:880-887.
  • [39]Kaplan RM, Ries AL: Quality of life: concept and definition. Copd 2007, 4:263-271.
  • [40]Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W, Louie S: Perception of fatigue and quality of life in patients with COPD. Chest 1998, 114:958-964.
  • [41]Hill K, Geist R, Goldstein RS, Lacasse Y: Anxiety and depression in end-stage COPD. Eur Respir J 2008, 31:667-677.
  • [42]Ninot G, Delignières D, Varray A: Individual differences in stability of physical self: examining the role of chronic obstructive pulmonary disease. Eur Rev Appl Psychol 2010, 60:35-40.
  • [43]Beaton DE, Boers M, Wells GA: Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002, 14:109-114.
  文献评价指标  
  下载次数:19次 浏览次数:20次